Therillia Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
Therillia General Information
Description
Developer of novel drug candidates designed to provide proof of concept strategies from pre-clinical to clinical stage. The company's drug candidate identifies potential responder patient populations, rational drug combinations, and the utility of clinical biomarkers, enabling sustainable biopharmaceutical companies to reduce the time and cost of achieving proof of concept data for important new therapeutics.
Contact Information
Website
www.therillia.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1000 De La Gauchetière Street West
- Suite 2100
- Montreal, Quebec H3B 4W5
- Canada
+1 (514) 000-0000
Therillia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Jul-2022 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
Therillia Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ramy Hobeika | Controller | ||
| Rosa Pierro | Executive | ||
| Michael Dixon | Chief Executive Officer, President & Board Member |
Therillia Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Michael Dixon | Self | Chief Executive Officer, President & Board Member | 000 0000 |
Therillia Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Therillia Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 18-Apr-2019 | 0000000000 | Biotechnology |
Therillia Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000 000000000000 | Biotechnology | Montreal, Canada | 0000 |
Therillia Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000 000000000000 | 18-Apr-2019 | 000000000000000000 | Completed |
|